William Riedl

William Riedl has worked in various scientific roles since 2012. In 2012, they were a Student Researcher at Chromatin, Inc., where they were responsible for maintenance of proprietary transgenic plant cell lines, analysis of gene presence in transgenic plant cell lines, and buffer and reagent preparation. From 2013-2015, they were an Undergraduate Research Assistant at the University of Illinois at Urbana-Champaign, where they worked on an independent thesis project studying a cytotoxin secreted by the bacterium Helicobacter pylori. From 2015-2020, they were a Graduate Student Researcher at the University of Chicago, where they identified and characterized the molecular mechanism by which Zika virus evades the innate immune response mediated through the intracellular pattern recognition receptors of RNA, RIG-I and MDA5. In 2020, they were an Entrepreneurial Lead at the Polsky Center I-Corps Program, where they conducted a nationwide customer discovery process and collaborated in a small team to conduct 25 customer discovery interviews. Currently, they are a Research Scholar at the Cleveland Clinic and a Senior Scientist at NeuBase Therapeutics, Inc.

William Riedl completed a Bachelor of Science in Molecular and Cellular Biology from the University of Illinois Urbana-Champaign in 2015. Following this, they went on to pursue a Doctor of Philosophy in Microbiology from the University of Chicago, which they completed in 2020.